"Mount Sinai Invests $200M into New Precision Medicine Data Science Program"
Icahn School of Medicine at Mount Sinai is investing $200 million into a new program to fast-track drug discoveries through the integration of large-scale data analysis and genomic technologies. The school also said it has recruited Adam Margolin, PhD, former director of computation biology at Oregon Health & Science University, to lead the initiative. Dr. Margolin, who will replace Eric Schadt at Mount Sinai, is a leader in the development of machine-learning algorithms to analyze large-scale datasets that predict which patients will respond to treatments. He has also developed software systems to enable collaborative analysis within national and international projects in cancer, genomics, cancer immunotherapy, stem cell research, and pediatric diseases. "We will bring together the top data scientists, genomic technology innovators, and disease experts who will work side by side every day to understand the molecular causes of complex diseases, rapidly test new therapies derived from these insights, and bring these therapies to patients faster than ever before,” said Dr. Margolin.
— Adam Margolin, PhD, Professor, Chair, Department of Genetics and Genomic Sciences, Senior Associate Dean, Precision Medicine, Director, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
Additional coverage:
Crain’s Health Pulse (Subscription required)
International Business Times
Star Tribune
Pittsburgh Post-Gazette
Investor Place
KFDA TV
The Buffalo News
Street Insider
KFMB TV
Health Data Management
DOT Med
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.
Mount Sinai and IBM Researchers Uncover Key to Greater Efficacy in Cancer Treatment
Mar 21, 2019 View All Press Releases
Sanofi, Sema4, Mount Sinai Collaborate on Largest Asthma Study of Its Kind
Dec 04, 2018 View All Press Releases